123 related articles for article (PubMed ID: 3021345)
1. Establishment of mutant murine mammary carcinoma FM3A cell strains transformed with the herpes simplex virus type 2 thymidine kinase gene.
Shimizu K; Ren L; Ayusawa D; Seno T; Balzarini J; De Clercq E
Cell Struct Funct; 1986 Sep; 11(3):295-301. PubMed ID: 3021345
[TBL] [Abstract][Full Text] [Related]
2. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
3. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
4. Establishment of mutant FM3A murine mammary carcinoma cell strains transformed with the herpes simplex virus type 1 thymidine kinase gene.
Ayusawa D; Shimizu K; Seno T; Balzarini J; De Clercq E
Jpn J Cancer Res; 1985 Oct; 76(10):984-8. PubMed ID: 3001011
[TBL] [Abstract][Full Text] [Related]
5. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
Balzarini J; de Clercq E; Ayusawa D; Seno T
FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041
[TBL] [Abstract][Full Text] [Related]
6. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
Balzarini J; Bohman C; De Clercq E
J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
Balzarini J; De Clercq E; Ayusawa D; Shimizu K; Seno T
Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708
[TBL] [Abstract][Full Text] [Related]
8. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.
Kit S; Sheppard M; Ichimura H; Nusinoff-Lehrman S; Ellis MN; Fyfe JA; Otsuka H
Antimicrob Agents Chemother; 1987 Oct; 31(10):1483-90. PubMed ID: 2829709
[TBL] [Abstract][Full Text] [Related]
10. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
[TBL] [Abstract][Full Text] [Related]
11. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
Degrève B; De Clercq E; Balzarini J
Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.
Panet A; Falk H
J Gen Virol; 1983 Sep; 64 (Pt 9)():1999-2006. PubMed ID: 6193244
[TBL] [Abstract][Full Text] [Related]
13. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
Balzarini J; Bohman C; Walker RT; de Clercq E
Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus thymidine kinase activity of thymidine kinase-deficient Escherichia coli K-12 mutant transformed by hybrid plasmids.
Kit S; Otsuka H; Qavi H; Hazen M
Proc Natl Acad Sci U S A; 1981 Jan; 78(1):582-6. PubMed ID: 6264449
[TBL] [Abstract][Full Text] [Related]
15. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
Saijo M; Suzutani T; Yoshida I
Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
Nugier F; Colin JN; Aymard M; Langlois M
J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.
Tanaka S; Toh Y; Mori R
Arch Virol; 1993; 131(1-2):61-73. PubMed ID: 8392322
[TBL] [Abstract][Full Text] [Related]
18. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
[TBL] [Abstract][Full Text] [Related]
19. Preliminary characterization of a mutant of herpes simplex virus type 1 selected for acycloguanosine resistance in vitro.
Palú G; Summers WP; Valisena S; Tognon M
J Med Virol; 1988 Mar; 24(3):251-62. PubMed ID: 2835423
[TBL] [Abstract][Full Text] [Related]
20. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G
J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]